STAT+: Pharmalittle: We’re reading about Trump’s drug tariffs, a U.S.-U.K. pharma trade deal, and more
Stat News • 3/25/2026 – 4/3/2026
Summary
No summary yet.
Advertisement
Cluster Activity
3
1
1
1
1
2
1
2026-03-252026-04-03
Lindy Score Breakdown (V4.2)
23h
Age
2
Sources
from cluster
22
Hours Since Seen
Final Score21/100
CategoryLindy
StatusActive
Recency Multiplier73% (0.5^22/48)
Hero EligibleYes
Story Timeline
- 2026-03-25
- 2026-03-26
- 2026-03-30
- 2026-03-31
- 2026-04-01
- 2026-04-02
- 2026-04-03STAT+: Pharmalittle: We’re reading about Trump’s drug tariffs, a U.S.-U.K. pharma trade deal, and more (current)
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Emerging consensus: 2 sources
Age: 1 day(s) old - still early
Stories gain Lindy status through source reputation, network consensus, and time survival.
Same Story from 10 sources
STAT+: Pharmalittle: We’re reading about Trump tariff plans, FDA’s OK for a Lilly obesity pill, and more
Stat News • 2 days ago
STAT+: Trump administration prepares 100% tariffs on some imported drugs
Stat News • 2 days ago
Trump administration readies new tariffs on select drugmakers, Bloomberg News reports
Reuters • 2 days ago
STAT+: Pharmalittle: We’re reading about pharma delaying launches in Europe, Lilly and Biogen deals, and more
Stat News • 4 days ago
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 5 days ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago
STAT+: Merck to buy Terns Pharmaceuticals in $6.7B deal
Stat News • 1 week ago
Breaking Similar stories
STAT+: Pharmalittle: We’re reading about Trump tariff plans, FDA’s OK for a Lilly obesity pill, and more
Stat News • 2 days ago
STAT+: NIH would get $5 billion cut under Trump’s 2027 budget, but Congress unlikely to go along
Stat News • Today
STAT+: Small drugmakers, facing threat of tariffs, negotiate pricing deals with White House
Stat News • 1 day ago
STAT+: Trump announces 100% tariffs on brand-name drugs, with plenty of carveouts
Stat News • 1 day ago
STAT+: Trump administration prepares 100% tariffs on some imported drugs
Stat News • 2 days ago
STAT+: How health care could gum up Trump’s reconciliation push
Stat News • 1 day ago
STAT+: Lilly’s obesity pill enters the oral GLP-1 game, Novo responds
Stat News • 2 days ago
Opinion: STAT+: Cardiology’s finally prioritizing prevention — but what will it look like?
Stat News • 2 days ago
STAT+: Proposed ‘preclinical obesity’ diagnosis ignites global debate among experts
Stat News • 2 days ago
STAT+: Government watchdog urges FDA to finalize guidance for advisory committee conflicts of interest
Stat News • 2 days ago
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about pharma delaying launches in Europe, Lilly and Biogen deals, and more
Stat News • 4 days ago
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 5 days ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago
STAT+: Merck to buy Terns Pharmaceuticals in $6.7B deal
Stat News • 1 week ago